Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant
- PMID: 40492500
- DOI: 10.1002/ajh.27738
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant
Keywords: BMT; haploidentical; marrow/stem cell transplantation‐clinical care of graft‐versus‐host disease; melphalan; transplantation.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
